We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$40.3B
AUM Growth
-$1.82B
Cap. Flow
+$332M
Cap. Flow %
0.83%
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$231M
2
GILD icon
Gilead Sciences
GILD
+$113M
3
PCG icon
PG&E
PCG
+$102M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$80.2M
5
ALL icon
Allstate
ALL
+$64.4M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$472M
2
ABBV icon
AbbVie
ABBV
+$121M
3
VLUE icon
iShares MSCI USA Value Factor ETF
VLUE
+$69.5M
4
CRM icon
Salesforce
CRM
+$64.3M
5
HD icon
Home Depot
HD
+$62.4M

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Healthcare 19.03%
3 Financials 13.02%
4 Consumer Discretionary 9.39%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCEL
1826
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$228K ﹤0.01%
145,166
DICE
1827
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$227K ﹤0.01%
+11,177
New +$204K
ALLO icon
1828
Allogene Therapeutics
ALLO
$573M
$226K ﹤0.01%
20,910
+2,120
+11% +$28.8K
CBZ icon
1829
CBIZ
CBZ
$2.51B
$226K ﹤0.01%
+5,290
New +$231K
INGN icon
1830
Inogen
INGN
$174M
$226K ﹤0.01%
9,315
JRVR icon
1831
James River Group Holdings
JRVR
$222M
$226K ﹤0.01%
9,900
PGRE
1832
DELISTED
Paramount Group
PGRE
$226K ﹤0.01%
+36,340
New +$262K
TVRD
1833
Tvardi Therapeutics
TVRD
$23M
$225K ﹤0.01%
669
-92
-12% -$33.3K
ESTA icon
1834
Establishment Labs
ESTA
$2.7B
$223K ﹤0.01%
4,090
+1,260
+45% +$75.3K
PCOR icon
1835
Procore
PCOR
$7.37B
$223K ﹤0.01%
+4,510
New +$242K
USNA icon
1836
Usana Health Sciences
USNA
$429M
$223K ﹤0.01%
3,970
-30
-0.8% -$1.98K
VMEO
1837
DELISTED
Vimeo
VMEO
$223K ﹤0.01%
55,810
+20,460
+58% +$121K
BBBY
1838
Bed Bath & Beyond
BBBY
$502M
$221K ﹤0.01%
9,977
LWLG icon
1839
Lightwave Logic
LWLG
$886M
$221K ﹤0.01%
30,100
SBGI icon
1840
Sinclair Inc
SBGI
$1.02B
$221K ﹤0.01%
12,210
FOCS
1841
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$221K ﹤0.01%
+7,000
New +$267K
GTN icon
1842
Gray Television
GTN
$430M
$220K ﹤0.01%
+15,380
New +$282K
LEGN icon
1843
Legend Biotech
LEGN
$3.68B
$220K ﹤0.01%
5,400
+3,300
+157% +$155K
NKTR icon
1844
Nektar Therapeutics
NKTR
$2.39B
$220K ﹤0.01%
4,581
PATH icon
1845
UiPath
PATH
$6.32B
$219K ﹤0.01%
17,368
XPEL icon
1846
XPEL
XPEL
$1.21B
$219K ﹤0.01%
3,400
+2,410
+243% +$157K
CDMO
1847
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$219K ﹤0.01%
11,460
+2,550
+29% +$46.5K
EBIX
1848
DELISTED
Ebix Inc
EBIX
$219K ﹤0.01%
11,534
-1,290
-10% -$28.4K
ATRA icon
1849
Atara Biotherapeutics
ATRA
$70.5M
$217K ﹤0.01%
2,296
-6,805
-75% -$764K
BATRK icon
1850
Atlanta Braves Holdings Series B
BATRK
$3.27B
$216K ﹤0.01%
+7,850
New +$214K

Similar funds

Ensign Peak Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
  • Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
  • Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
  • Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
  • Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
  • Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.